Literature DB >> 14633845

Microvascular complications of impaired glucose tolerance.

J Robinson Singleton1, A Gordon Smith, James W Russell, Eva L Feldman.   

Abstract

Impaired glucose tolerance (IGT) serves as a marker for the state of insulin resistance and predicts both large- and small-vessel vascular complications, independent of a patient's progression to diabetes. Patients with IGT are at significantly increased risk for death and morbidity due to myocardial infarction, stroke, and large-vessel occlusive disease. IGT is more predictive of cardiovascular morbidity than impaired fasting glucose, probably because it is a better surrogate for the state of insulin resistance. IGT is also independently associated with traditional microvascular complications of diabetes, including retinopathy, renal disease, and polyneuropathy, which are the topics of this review. Inhibition of nitric oxide-mediated vasodilation, endothelial injury due to increased release of free fatty acids and adipocytokines from adipocytes, and direct metabolic injury of endothelial and end-organ cells contribute to vascular complications. Early detection of IGT allows intensive diet and exercise modification, which has proven significantly more effective than drug therapy in normalizing postprandial glucose and inhibiting progression to diabetes. To what degree intervention will limit recognized complications is not known.

Entities:  

Mesh:

Year:  2003        PMID: 14633845     DOI: 10.2337/diabetes.52.12.2867

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  93 in total

1.  Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitus.

Authors:  Thomas Forst; Matthias M Weber; Michael Mitry; Thomas Schöndorf; Senait Forst; Mukadar Tanis; Andreas Pfützner; Georg Michelson
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 2.  Exercise as Therapy for Diabetic and Prediabetic Neuropathy.

Authors:  J Robinson Singleton; A Gordon Smith; Robin L Marcus
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 3.  Neuropathy in prediabetes: does the clock start ticking early?

Authors:  Nikolaos Papanas; Aaron I Vinik; Dan Ziegler
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

4.  Differential inhibition by hyperglycaemia of shear stress- but not acetylcholine-mediated dilatation in the iliac artery of the anaesthetized pig.

Authors:  R Kelly; T Ruane-O'Hora; M I M Noble; A J Drake-Holland; H M Snow
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

5.  Determination of nerve conduction abnormalities in patients with impaired glucose tolerance.

Authors:  Sevki Sahin; Sibel Karsidag; Sunay Ayalp; Ahmet Sengul; Onder Us; Kubilay Karsidag
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

6.  Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation.

Authors:  Amanda Peltier; A Gordon Smith; James W Russell; Kiran Sheikh; Billie Bixby; James Howard; Jonathan Goldstein; Yanna Song; Lily Wang; Eva L Feldman; J Robinson Singleton
Journal:  Muscle Nerve       Date:  2009-04       Impact factor: 3.217

7.  Treatment of diabetic sensory polyneuropathy.

Authors:  Lindsay Zilliox; James W Russell
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

8.  Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression.

Authors:  F Oriente; S Iovino; A Cassese; C Romano; C Miele; G Troncone; M Balletta; A Perfetti; G Santulli; G Iaccarino; R Valentino; F Beguinot; P Formisano
Journal:  Diabetologia       Date:  2009-09-30       Impact factor: 10.122

9.  FOXO1 plays an essential role in apoptosis of retinal pericytes.

Authors:  Mani Alikhani; Sayon Roy; Dana T Graves
Journal:  Mol Vis       Date:  2010-03-10       Impact factor: 2.367

10.  A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project.

Authors:  Silmara Ao Leite; Robyn L Anderson; David M Kendall; Arlene M Monk; Richard M Bergenstal
Journal:  Diabetol Metab Syndr       Date:  2009-09-16       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.